BCAT1 and glioblastoma: Consistently, we found that glutamate replenishment can significantly enhance the expression of TxN in GBM cells lacking BCAT1 expression, while the application of sulfasalazine (SSA), a chemical inhibitor of the Xc-transporter, inhibited the effect of glutamate replenishment (Figure 3J).